A National Directory of Drug Treatment Centers and Alcohol Treatment Centers, Therapists and Specialists. A free, simple directory providing assistance and guidance for those seeking help regarding alcohol addiction, drug addiction, dependency and many other conditions that affect the mind, body and soul.
Call 800-580-9104 to speak with an alcohol or drug abuse counselor.

New Medications May Offer Hope to Drinkers Battling Alcohol Dependence

Individuals who experience the physical, mental and social symptoms associated with alcohol dependence are offered hope through the results of two recent studies by researchers at the Medical University of South Carolina (MUSC). In separate investigations, researchers found favorable results for a medication to help heavy drinkers who are trying to modify their consumption, as well as a medication to reduce alcohol withdrawal symptoms and prevent relapse.

In a landmark study, MUSC researchers working with investigators at the University of Virginia Health System and elsewhere have found that topiramate, an effective therapeutic medication, not only decreases heavy drinking, but it also lowers all liver enzymes, plasma cholesterol, body mass index (BMI), and systolic and diastolic blood pressure — all of which tend to increase with heavy drinking and pose such serious health risks as heart disease and cirrhosis. Notably, these combined effects suggest that topiramate may decrease the risk of heart disease in alcohol dependent individuals.

“These findings add growing data indicating that heavy drinkers who modify their drinking with the help of medication and supportive counseling may see an improvement in health and well-being, as well as a potential reduction of risk for the development of heart and liver diseases. This shows that treatment of alcoholism has potential health benefits beyond the immediate behavioral and emotional improvement caused by a reduction in drinking” said Raymond Anton, M.D., distinguished university professor.

By decreasing liver enzymes and cholesterol levels, topiramate also may reduce the risk of fatty liver disease, which leads to cirrhosis – a common consequence to end-stage liver disease leading to death in some alcoholics.

Additionally, topiramate significantly contributed to a decline in obsessive thoughts and compulsions, components of alcohol craving, and also had a greater improvement in their “overall quality of life,” and specifically an improvement in general and leisure activities and household duties, as well as a reduction in sleep disturbances.

The Food and Drug Administration has approved topiramate for seizures and migraine headaches, but it is not currently approved for treating alcohol dependence. Ortho-McNeil Neurologics, Inc., manufactures topiramate and provided study funding.

Results from the nationwide 14-week trial involving 371 male and female diagnosed alcoholics was published in the June 9 issue of the Archives of Internal Medicine.

In addition, Anton presented initial results from a separate investigation of a 14-week double-blind, placebo-controlled study utilizing the PROMETA ® alcoholism treatment program, developed by Hythiam, inc., at the 2008 Research Society on Alcoholism (RSA) conference in Washington D.C.

Anton suggested that alcohol dependence programs are few in number and not exceptionally effective, which is particularly true for individuals who experience alcohol withdrawal symptoms. PROMETA ®, a combination of generic medications, reduced cravings and alcohol withdrawal symptoms, promoted abstinence, and improved mood and sleep only in those who had symptoms of alcohol withdrawal. Although the PROMETA ® Protocol has been marketed nationally, this was the first scientific study examining its utility in individuals with alcohol dependence.

At the time of the RSA presentation, the data presented covered the initial six-week active treatment phase of the 14-week study. While these are initial findings, additional evaluation of the full 14-week study data is ongoing, and Anton plans to release these specifics in a peer-reviewed publication.

MUSC has an ongoing clinical trial program studying new medications for the treatment of alcohol use disorders. For more information call 843-792-2727.
__________
source: Newswise Medical News

More Treatment & Detox Articles

Helping a Loved One through Bulimia Treatment and Recovery

recovery from bulimia

Hardships of Bulimia According to the National Eating Disorders Association, bulimia is a serious and potentially life-threatening eating disorder. Bulimia is characterized by a cycle of bingeing and compensatory behaviors, which include self-induced vomiting to undo or compensate for the effects of binge eating. Bulimia is a devastating eating disorder that will have numerous negative….

Continue reading

Try These Therapies Before Giving Up Hope in Treatment

Are you in a treatment program and about to give up hope? Has the treatment you’re receiving seemingly lost it’s effectiveness or have you had difficulty recovering from addiction despite your trying many different types of treatment? It’s not uncommon to hit a plateau when you are receiving addiction treatment and to require a change….

Continue reading

Diagnosis of ADHD

Attention Deficit Hyperactivity Disorder is termed as ADHD. This disorder is commonly seen in small children. The children suffering from ADHD disorder are very impulsive, hyperactive and find it difficult to concentrate. Since, this kind of behavior is common in small children; it becomes difficult to differentiate between normal behavior and ADHD disorder. Therefore, it….

Continue reading

Alcohol Abuse and Economic Downturns

The economy is cascading downward at a rate unheard of since the early thirties. Unemployment is rising at a staggering pace, and many flagship industries are closing their doors or cutting production, adding thousands more workers to the unemployment line. President Obama’s stimulus package is designed to stop the economic hemorrhaging and return the nation….

Continue reading

Who Needs Crystal Meth Treatment?

One of the fastest growing drug problems and also one of the most dangerous epidemics in the United States is the use of crystal meth. Methamphetamine is a highly addictive street drug that was once only found to be prevalent in rural areas but can now be found dominating thousands of US cities and towns,….

Continue reading